May 20th opens the National Epilepsy Week. Epilepsy is one of the most common neurological diseases, and it can affect people of all ages.
However, epileptic seizures can be controlled, and up to 70% of people living with epilepsy could become seizure free via the use of appropriate and affordable anti-seizure medicines. Yet, according to WHO, most of the people with epilepsy living in the middle- and low- income countries do not get the treatment they need.
GCT has conducted a number of clinical trials in Epilepsy: both adult and pediatric population. Please contact us at bd@gctrials.com for more information about our experience and services.